Price Movement and Market Context
On 9 January 2026, Thyrocare Technologies Ltd closed at ₹446.00, down 3.78% from the previous close of ₹463.50. The intraday range was between ₹440.00 and ₹460.60, indicating some volatility. The stock remains well below its 52-week high of ₹532.59 but comfortably above its 52-week low of ₹217.14, suggesting a broad trading range over the past year.
Comparatively, Thyrocare has outperformed the Sensex over the past year, delivering a 43.63% return against the benchmark’s 7.72%. Over three years, the stock’s return of 129.6% significantly eclipses the Sensex’s 40.53%, underscoring strong medium-term growth. However, over five years, the stock’s 39.4% return trails the Sensex’s 72.56%, indicating some recent deceleration relative to the broader market.
Technical Trend Shift: From Bullish to Mildly Bullish
The technical trend for Thyrocare has shifted from bullish to mildly bullish, signalling a moderation in upward momentum. This nuanced change reflects a market that is less confident in sustained gains but not yet bearish. The daily moving averages remain mildly bullish, supporting a cautiously optimistic near-term outlook.
Weekly and monthly indicators, however, paint a more mixed picture. The Moving Average Convergence Divergence (MACD) is mildly bearish on the weekly chart but bullish on the monthly, suggesting short-term weakness amid longer-term strength. The Relative Strength Index (RSI) shows no clear signal on either timeframe, indicating a neutral momentum without overbought or oversold extremes.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
Bollinger Bands and KST Indicator Insights
Bollinger Bands on both weekly and monthly charts are mildly bullish, indicating that price volatility is contained within an upward trending channel. This suggests that despite recent price dips, the stock is maintaining a degree of upward pressure and has not broken down into a bearish pattern.
The Know Sure Thing (KST) indicator, which measures momentum across multiple timeframes, is mildly bearish on the weekly chart but bullish on the monthly. This divergence highlights short-term caution among traders, while longer-term momentum remains intact. Such mixed signals often precede consolidation phases or moderate corrections.
Volume and Dow Theory Analysis
On-Balance Volume (OBV) remains bullish on both weekly and monthly charts, signalling that buying pressure continues to support the stock despite recent price weakness. This is a positive sign for investors looking for confirmation that institutional interest remains steady.
Dow Theory assessments are mildly bullish on the weekly timeframe but mildly bearish on the monthly, reinforcing the theme of short-term uncertainty against a backdrop of longer-term caution. This suggests that while the stock may experience some near-term volatility, the broader trend is still under evaluation by market participants.
Mojo Score Upgrade and Market Capitalisation Grade
MarketsMOJO has upgraded Thyrocare Technologies Ltd’s Mojo Grade from Hold to Buy as of 10 November 2025, reflecting improved confidence in the stock’s prospects. The current Mojo Score stands at 70.0, signalling a favourable outlook based on a combination of fundamental and technical factors.
The company’s Market Cap Grade is 3, indicating a mid-sized market capitalisation within the healthcare services sector. This positioning offers a balance between growth potential and relative stability compared to larger peers.
Want to dive deeper on Thyrocare Technologies Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Investor Takeaways and Outlook
Investors should note that Thyrocare Technologies Ltd is currently navigating a phase of technical consolidation. The mildly bullish daily moving averages and bullish monthly MACD suggest that the stock retains upside potential, but the weekly bearish signals and recent price decline caution against aggressive positioning.
Given the mixed technical signals, a prudent approach would be to monitor key support levels near ₹440 and resistance around ₹460-470. A sustained break above the recent high of ₹460.60 could reignite bullish momentum, while a drop below ₹440 may signal deeper correction risks.
Longer-term investors may find comfort in the stock’s strong relative performance over one and three years, as well as the positive volume trends. However, the divergence in technical indicators advises careful timing and risk management.
Overall, the upgrade to a Buy rating by MarketsMOJO reflects a positive fundamental backdrop complemented by cautiously optimistic technicals. The healthcare services sector continues to offer growth opportunities, and Thyrocare’s market position and momentum metrics support a constructive outlook with measured risk.
Summary of Key Technical Indicators
- MACD: Weekly mildly bearish, Monthly bullish
- RSI: Neutral on both weekly and monthly
- Bollinger Bands: Mildly bullish on weekly and monthly
- Moving Averages: Daily mildly bullish
- KST: Weekly mildly bearish, Monthly bullish
- Dow Theory: Weekly mildly bullish, Monthly mildly bearish
- OBV: Bullish on weekly and monthly
These mixed signals suggest a stock in transition, with momentum indicators urging caution but not signalling a definitive downtrend. Investors should weigh these factors alongside fundamental analysis and sector trends when considering positions in Thyrocare Technologies Ltd.
Unlock special upgrade rates for a limited period. Start Saving Now →
